Quantcast
Channel: Health VC Feed » pharma
Browsing latest articles
Browse All 156 View Live

Image may be NSFW.
Clik here to view.

Novartis hands off experimental tuberculosis drugs to TB Alliance in move...

ZURICH (Reuters) – Novartis has signed a licensing deal to hand over its experimental tuberculosis (TB) drugs to the Global Alliance for TB Drug Development, joining a growing Big Pharma …

View Article


Image may be NSFW.
Clik here to view.

ViaCyte, Janssen ink deal over stem cell-derived islet replacement therapy...

US regenerative medicine company ViaCyte Inc said Thursday it had signed a rights deal with Janssen Research & Development LLC, part of US Johnson & Johnson (NYSE:JNJ), under which Janssen …

View Article

Image may be NSFW.
Clik here to view.

Roche is beefing up its respiratory drug portfolio with InterMune takeover

Swiss Roche (VTX:ROG) has agreed to purchase California-based pulmonology and fibrotic disease therapy maker InterMune Inc (NASDAQ:ITMN) for USD 8.3 billion (EUR 6.3bn), or USD 74.00 apiece, …

View Article

Image may be NSFW.
Clik here to view.

Avalon-GSK Collaboration Generates Two More Startups in San Diego

Bruce V. Bigelow San Diego’s Avalon Ventures is taking the wraps off two new startups today, with each one getting as much as $10 million in Series A financing through …

View Article

Image may be NSFW.
Clik here to view.

Merrimack, Baxter Ink $970M+ Deal for Pancreatic Cancer Drug

Ben Fidler It’s been an up and down year for Merrimack Pharmaceuticals. On one hand, the Cambridge, MA-based company succeeded in a Phase 3 trial in the notoriously tough field …

View Article


Should I Stay Or Should I Go? Big Pharma Execs Taking The Biotech Plunge

That’s the dilemma facing drug hunters as leadership roles in biotech become more and more attractive.  You may have noticed that more and more seasoned pharma executives are making …

View Article

Image may be NSFW.
Clik here to view.

HealthPrize inks deal to track medication adherence for injectables

HealthPrize Technologies has inked a deal with West Pharmaceuticals that will expand the company’s medication adherence meets gaming technology to injectable drugs that are self-administered, according...

View Article

Image may be NSFW.
Clik here to view.

Texas Medical Center Makes Pitch to Boost Houston Biotech Startups

Angela Shah The Texas Medical Center is slated this week to unveil its new life sciences accelerator, to be housed in a former Nabisco cookie factory near its main Houston …

View Article


Lowering the Cost of Failure in Biopharmaceuticals

Court Chilton In any business, projects fail, but in biopharmaceuticals, the consequences of failure are especially damaging. Projects in the industry tend to be long and expensive—from clinical...

View Article


Image may be NSFW.
Clik here to view.

Cystic Fibrosis Drug Developer N30 Pharmaceuticals Raises $30M

Michael Davidson N30 Pharmaceuticals, a Boulder-based pharmaceutical company developing drugs for cystic fibrosis, announced yesterday it has raised a $30 million mezzanine financing round. N30 Pharma...

View Article

Image may be NSFW.
Clik here to view.

Array and Novartis End Development Deal for Cancer Drug Binimetinib

Michael Davidson Drug developer Array BioPharma and pharmaceutical giant Novartis are going separate ways, but that doesn’t seem to be bad news for Boulder, CO-based Array. The companies announced...

View Article

Image may be NSFW.
Clik here to view.

Oncothyreon Pays $20M for Array BioPharma’s Breast Cancer Drug

Michael Davidson Oncothyreon and Array BioPharma announced today that they have updated their development agreement around a breast cancer drug invented by Array. Oncothyreon, based in Seattle, will...

View Article

Image may be NSFW.
Clik here to view.

Insulin inhaler Afrezza could launch in U.S. next year under Sanofi-MannKind...

French pharmaceutical group Sanofi (EPA:SAN) and US biopharmaceutical company MannKind Corp (NASDAQ:MNKD) have signed a global exclusive licence deal to develop and market Afrezza (insulin human)...

View Article


Japan’s Chugai Pharmaceuticals: We’re not being acquired by Roche

Japan-based Chugai Pharmaceuticals has released a statement that denies reports that the company is to be acquired by Roche, a Swiss drug company, it was reported yesterday. The Japanese company ...

View Article

10 Bits of Advice for Students Interested in Drug Development

Daniel Sem Here are my 10 crucial pieces of advice for students who aspire to a career in pharmaceutical labs: 1. You need a solid foundation in science. Master the (Read more...)

View Article

Browsing latest articles
Browse All 156 View Live